![Global Biomarkers Market](https://res.cloudinary.com/devmoveo/image/upload/v1683887117/skyquest/gallery/Global-Biomarkers-Market.jpg)
Report ID: SQMIG35A2509
Report ID:
SQMIG35A2509 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|
Tables:
92 |
Figures:
76
North America accounted for the largest biomarkers market revenue share in 2023 with over 44%. 00% to factors such as the high illness burden, rising awareness of biomarkers, favorable government policies, technology advances, and enhanced health care systems. The strategic location of this area and the various organic and inorganic activities implemented by significant enterprises are key determinants expected to boost this region. For instance, in November 2023 Akoya Biosciences, Inc. launched PhenoCode signature panels for high-throughput spatial biomarker discovery.
Asia-Pacific, however, is expected to grow at the fastest rate throughout that particular period. Increased funding for biomarker growth, a high cancer incidence rate, increased activity in research, and affordable clinical trials in developing countries are some of the factors that are expected to drive regional growth. Moreover, it is expected that rising funding for biotech and pharmaceutical enterprises, growing CRO numbers, and expanding biomarker applications will foster regional market growth for the predicted timeframe.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2509